Interestingly, in the contralateral hemisphere no vimentin+ cells were detected either after peptide R or Plerixafor treatment (Fig. 3c), suggesting that both CXCR4 antagonists could abrogate dissemination of glioblastoma cells at distant cerebral sites. This evidence concerns the gene VIM and glioblastoma.